HLVX logo

HilleVax (HLVX)

Profile

Full Name

HilleVax, Inc.

Ticker Symbol

HLVX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 29, 2022

Indexes

Not included

Website

http://www.hillevax.com

Employees

14

Key Details

Price

$1.83(-1.61%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.00(+1.32% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.83
    HLVX price is $1.83

    30-Day Relative Volume

    0.42
    HLVX 30-day relative volume is 0.42

    Price Performance

    Price Most recent change

    -1.61%
    HLVX price was down -1.61% on May 28, 2025

    Price YTD change

    -11.59%
    HLVX price is down -11.59% since January 1st

    Price 1-year change

    -85.52%
    HLVX price is down -85.52% year-on-year

    Price 3-year change

    -80.9%
    HLVX price is down -80.9% over the past 3 years

    Price Range

    Price All-time high

    $24.42
    HLVX price is currently -92.51% below its historical high of $24.42

    Price 3-year low

    $1.34
    HLVX price is currently +36.57% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $91.68M
    HLVX market capitalization is $91.68 million

    Market cap 3-year change

    -71.37%
    HLVX market capitalization is down -71.37% over the past 3 years

    Market cap All-time high

    $941.41M
    HLVX market capitalization is currently -90.26% below its historical high of $941.41 million

    Market cap sector rank

    45.3%
    HLVX market capitalization is higher than 45.3% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.76%
    HLVX shares outstanding is up +0.76% year-on-year

    Shares Outstanding 3-Year Change

    +49.88%
    HLVX shares outstanding is up +49.88% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.66
    HLVX beta is 0.66

    200-day SMA

    $1.84
    HLVX price is currently -0.28% below its 200-day simple moving average

    50-day SMA

    $1.75
    HLVX price is currently +4.54% above its 50-day simple moving average

    RSI

    46.53
    HLVX 14-day relative strength index is 46.53

    Volume

    0.42
    HLVX 30-day relative volume is 0.42

    ATR

    $0.08
    HLVX average true range is $0.08

    10-day Historical Volatility

    41.55%
    HLVX 10-day historical volatility is 41.55%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    HLVX annual revenue value is unknown

    Revenue Analysts estimate

    -
    HLVX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    HLVX annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    HLVX annual revenue is unknown

    EPS

    EPS

    -$3.00
    HLVX annual earnings per share is -$3.00

    EPS Analysts estimate

    -$2.29
    HLVX annual earnings per share is currently +31.00% higher than the consensus analysts' forecast

    EPS 1-year change

    +1.32%
    HLVX annual earnings per share is up +1.32% year-on-year

    EPS Sector rank

    28.85%
    HLVX annual earnings per share is higher than 28.85% of companies in Healthcare sector

    Profit

    Gross profit

    -
    HLVX annual gross profit value is unknown

    Gross margin

    -
    HLVX annual gross profit margin value is unknown

    Operating profit

    -$106.96M
    HLVX annual operating income is -$106.96 million

    Operating margin

    -
    HLVX annual operating profit margin value is unknown

    Net income

    -$147.27M
    HLVX annual net profit is -$147.27 million

    Net margin

    -
    HLVX annual net profit margin value is unknown

    Expenses

    Total expenses

    $106.96M
    HLVX annual total expenses is $106.96 million

    Operating expenses

    $106.96M
    HLVX annual total operating expenses is $106.96 million

    Cost of goods sold

    -
    HLVX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $28.79M
    HLVX annual SGA is $28.79 million

    Depreciation and amortization

    $3.20M
    HLVX annual depreciation & amortization is $3.20 million

    Interest expense

    $3.32M
    HLVX annual interest expense is $3.32 million

    Income tax

    -
    HLVX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$143.95M
    HLVX annual earnings before interest & taxes is -$143.95 million

    EBITDA

    -$140.75M
    HLVX annual EBITDA is -$140.75 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $192.69M
    HLVX annual total assets is $192.69 million

    Non current assets

    $14.34M
    HLVX annual long term assets is $14.34 million

    Current assets

    $178.35M
    HLVX annual total current assets is $178.35 million

    Cash and cash equivalents

    $154.47M
    HLVX annual cash & cash equivalents is $154.47 million

    Accounts receivable

    -
    HLVX annual accounts receivable value is unknown

    Inventory

    -
    HLVX annual inventory value is unknown

    Liabilities

    Total liabilities

    $38.20M
    HLVX annual total liabilities is $38.20 million

    Long term liabilities

    $21.75M
    HLVX annual total long term liabilities is $21.75 million

    Current liabilities

    $16.45M
    HLVX annual total current liabilities is $16.45 million

    Accounts payable

    $3.24M
    HLVX annual accounts payable is $3.24 million

    Debt

    Total debt

    $24.51M
    HLVX annual total debt is $24.51 million

    Total debt 1-year change

    -52.12%
    HLVX annual total debt is down -52.12% year-on-year

    Long term debt

    $20.94M
    HLVX annual long term debt is $20.94 million

    Short term debt

    $3.57M
    HLVX annual short term debt is $3.57 million

    Equity & Capital

    Shareholders equity

    $154.49M
    HLVX annual stockholders equity is $154.49 million

    Book value

    $154.49M
    HLVX annual book value is $154.49 million

    Retained earnings

    -$535.83M
    HLVX annual retained earnings is -$535.83 million

    Working capital

    $161.89M
    HLVX annual working capital is $161.89 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$108.79M
    HLVX annual cash flow from operations is -$108.79 million

    Cash from operations 1-year change

    -25.36%
    HLVX annual cash flow from operations is down -25.36% year-on-year

    Cash from investing

    $58.40M
    HLVX annual cash flow from investing activities is $58.40 million

    Cash from investing 1-year change

    +161.71%
    HLVX annual cash flow from investing activities is up +161.71% year-on-year

    Cash from financing

    -$11.82M
    HLVX annual cash flow from financing activities is -$11.82 million

    Cash from financing 1-year change

    -109.96%
    HLVX annual cash flow from financing activities is down -109.96% year-on-year

    CAPEX

    CAPEX

    -
    HLVX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    HLVX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$124.64M
    HLVX annual free cash flow is -$124.64 million

    Free cash flow 1-year change

    -27.79%
    HLVX annual free cash flow is down -27.79% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    HLVX annual gross profit margin value is unknown

    Operating margin

    -
    HLVX annual operating profit margin value is unknown

    Net margin

    -
    HLVX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -76.43%
    HLVX annual return on assets is -76.43%

    ROE

    -95.33%
    HLVX annual return on equity is -95.33%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    HLVX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    HLVX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.61
    HLVX price to book ratio is 0.61

    PB ratio Sector rank

    29.78%
    HLVX price to book ratio is higher than 29.78% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    HLVX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    HLVX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $68.24M
    HLVX enterprise value is $68.24 million

    Enterprise value Sector rank

    42.53%
    HLVX enterprise value is higher than 42.53% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.68
    HLVX EV/EBITDA is -0.68

    EV/EBITDA Sector rank

    51.26%
    HLVX EV/EBITDA is higher than 51.26% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.84
    HLVX annual current ratio is 10.84

    Quick ratio

    -
    HLVX annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.16
    HLVX annual debt to equity ratio is 0.16

    Interest coverage ratio

    -43.38
    HLVX annual interest coverage ratio is -43.38

    Risk & Stability

    Piotroski F-Score

    -
    HLVX piotroski f-score value is unknown

    Altman Z-Score

    -
    HLVX altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Mar 31, 25 HC Wainwright & Co.
    Neutral
    Aug 12, 24 HC Wainwright & Co.
    Neutral
    Jul 9, 24 Stifel
    Hold
    Jul 9, 24 Leerink Partners
    Market Perform
    Jul 9, 24 HC Wainwright & Co.
    Neutral
    Jul 8, 24 JP Morgan
    Neutral
    Jul 8, 24 Guggenheim
    Neutral
    May 15, 24 JP Morgan
    Overweight
    May 10, 24 HC Wainwright & Co.
    Buy
    Mar 21, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with HLVX included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for HilleVax?
    • Does HilleVax pay dividends?
    • What sector is HilleVax in?
    • What industry is HilleVax in?
    • What country is HilleVax based in?
    • When did HilleVax go public?
    • Is HilleVax in the S&P 500?
    • Is HilleVax in the NASDAQ 100?
    • Is HilleVax in the Dow Jones?
    • When was HilleVax's last earnings report?
    • When does HilleVax report earnings?
    • Should I buy HilleVax stock now?

    What is the ticker symbol for HilleVax?

    The ticker symbol for HilleVax is NASDAQ:HLVX

    Does HilleVax pay dividends?

    No, HilleVax does not pay dividends

    What sector is HilleVax in?

    HilleVax is in the Healthcare sector

    What industry is HilleVax in?

    HilleVax is in the Biotechnology industry

    What country is HilleVax based in?

    HilleVax is headquartered in United States

    When did HilleVax go public?

    HilleVax's initial public offering (IPO) was on April 29, 2022

    Is HilleVax in the S&P 500?

    No, HilleVax is not included in the S&P 500 index

    Is HilleVax in the NASDAQ 100?

    No, HilleVax is not included in the NASDAQ 100 index

    Is HilleVax in the Dow Jones?

    No, HilleVax is not included in the Dow Jones index

    When was HilleVax's last earnings report?

    HilleVax's most recent earnings report was on May 8, 2025

    When does HilleVax report earnings?

    The next expected earnings date for HilleVax is Aug 8, 2025

    Should I buy HilleVax stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page